跳至主要内容
临床试验/NCT00449267
NCT00449267已完成4 期

Clinical Evaluation of Hydrophobic Foldable Intraocular Lenses

Aurolab2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年3月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Aurolab
入组人数
120
试验地点
2
主要终点
Visual acuity

研究概览

简要总结

The purpose of this study is to evaluate whether hydrophobic intraocular lenses manufactured by aurolab are safe and effective in the surgical treatment of cataract.

详细描述

Hydrophobic as the name suggests is fear for water. Hydrophobic foldable IOLs are made from acrylic material. Aurolab has developed its own hydrophobic acrylic material. This material has been subjected to several biocompatibility studies and it has proved itself to be biocompatible.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 40 to 65 years
  • Senile Cataract
  • Posterior Subcapsular Cataract (PSCC)

排除标准

  • Obviously debilitated patients
  • Cardiac and other serious illness
  • Diabetic Patients
  • Traumatic cataract
  • Complicated cataract
  • Congenital cataract
  • Drug induced cataract
  • Shallow anterior chamber
  • Poor mydriasis
  • Amblyopia
  • Pseudo exfoliation (PXF)
  • Dense posterior polar cataract (PPC)
  • One eyed patients
  • Corneal Pathology
  • Retinal Pathology
  • Intra operative complications like PC rupture, Zonular dialysis

结局指标

主要结局

Visual acuity

时间窗: 10days, 40 days, 150 days post operatively

次要结局

  • Refraction(10days, 40 days, 150 days post operatively)
  • Intraocular pressure(10days, 40 days, 150 days post operatively)
  • Corneal status(10days, 40 days, 150 days post operatively)
  • Iritis(10days, 40 days, 150 days post operatively)
  • IOL decentration(10days, 40 days, 150 days post operatively)
  • IOL tilt(10days, 40 days, 150 days post operatively)
  • IOL discoloration(10days, 40 days, 150 days post operatively)
  • IOL opacity(10days, 40 days, 150 days post operatively)
  • Cystoid macular oedema(10days, 40 days, 150 days post operatively)
  • Hypopyon(10days, 40 days, 150 days post operatively)
  • Endophthalmitis(10days, 40 days, 150 days post operatively)
  • Pupillary block(10days, 40 days, 150 days post operatively)
  • Retinal detachment(10days, 40 days, 150 days post operatively)
  • Status of anterior and posterior capsule(10days, 40 days, 150 days post operatively)

研究者

发起方
Aurolab
申办方类型
Other

研究点 (2)

Loading locations...

相似试验